Aziyo Biologics AZYO

$ 1.48 1.37%

Quarterly report 2024-Q3
added 11-14-2024

Aziyo Biologics Balance Sheet 2011-2024 | AZYO

Annual Balance Sheet Aziyo Biologics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	1.36 M	7.5 M	-11.9 M	-8.52 M	23 M	17.1 M	-	-	-	-	-	-	-
Long Term Debt	20.4 M	24.3 M	10.4 M	17.8 M	19.6 M	16.5 M	-	-	-	-	-	-	-
Long Term Debt Current	275 K	232 K	8.06 M	6.31 M	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	35.2 M	81.6 M	77.8 M	-	-	-	-	-	-	-
Total Current Liabilities	43 M	42.6 M	26 M	26.8 M	-	-	-	-	-	-	-	-	-
Total Liabilities	82 M	73.9 M	53.6 M	62 M	99.9 M	91.1 M	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	533 K	650 K	648 K	-	-	-	-	-	-	-
Retained Earnings	-176 M	-138 M	-105 M	-	-	-	-	-	-	-	-	-	-
Total Assets	43.4 M	68.8 M	67.2 M	82.8 M	44.8 M	47.7 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	19.3 M	17 M	30.4 M	39.2 M	2.59 M	-	-	-	-	-	-	-	-
Book Value	-38.6 M	-5.03 M	13.5 M	20.8 M	-55.1 M	-43.4 M	-	-	-	-	-	-	-
Total Shareholders Equity	-38.6 M	-5.03 M	13.5 M	20.8 M	-55.1 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Aziyo Biologics

	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	22.6 M	18.9 M	19.7 M	25.3 M	24.9 M	24.6 M	24.3 M	20 M	7.11 M	8.76 M	10.4 M	12 M	13.7 M	15.5 M	17.8 M	17.8 M	17.8 M	17.8 M	19.6 M	19.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	88.6 M	106 M	85.7 M	84.1 M	74.5 M	72.8 M	73.9 M	71.7 M	54.2 M	53.4 M	53.6 M	52 M	54.7 M	57.8 M	62 M	62 M	62 M	62 M	55.4 M	55.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	5 K	110 K	251 K	392 K	533 K	533 K	533 K	533 K	650 K	650 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-221 M	-222 M	-194 M	-166 M	-157 M	-146 M	-138 M	-133 M	-123 M	-113 M	-105 M	-96 M	-87.7 M	-85.3 M	-80.3 M	-80.3 M	-80.3 M	-80.3 M	-56.9 M	-56.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	48.4 M	41.9 M	35.4 M	54.6 M	52.3 M	60.6 M	68.8 M	61 M	52.9 M	59.9 M	67.2 M	59.9 M	69.7 M	74.2 M	82.8 M	82.8 M	82.8 M	82.8 M	44.8 M	44.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	25.7 M	18.2 M	12.6 M	14.5 M	9.3 M	11.8 M	17 M	8.1 M	16.5 M	22.2 M	30.4 M	22.5 M	28.3 M	30.4 M	39.2 M	39.2 M	39.2 M	39.2 M	2.48 M	2.48 M	-	-	2.41 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-40.2 M	-64.3 M	-50.3 M	-29.5 M	-22.1 M	-12.2 M	-5.03 M	-10.7 M	-1.37 M	6.56 M	13.5 M	7.86 M	15 M	16.4 M	20.8 M	20.8 M	20.8 M	20.8 M	-10.7 M	-10.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-40.2 M	-64.3 M	-50.3 M	-29.5 M	-22.1 M	-12.2 M	-5.03 M	-10.7 M	-1.37 M	6.56 M	13.5 M	7.86 M	15 M	16.4 M	20.8 M	20.8 M	20.8 M	20.8 M	-55.1 M	-55.1 M	-49.3 M	-	-43.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency